Guest, J.D.; Zhang, Y.; Flores, D.; Atkins, E.; Ren, K.; Cai, Y.; Rosenthal, K.; Wang, Z.; Kim, K.; Chen, C.;
et al. SARS-CoV-2 RBD Scaffolded by AP205 or TIP60 Nanoparticles and Delivered as mRNA Elicits Robust Neutralizing Antibody Responses. Vaccines 2025, 13, 778.
https://doi.org/10.3390/vaccines13080778
AMA Style
Guest JD, Zhang Y, Flores D, Atkins E, Ren K, Cai Y, Rosenthal K, Wang Z, Kim K, Chen C,
et al. SARS-CoV-2 RBD Scaffolded by AP205 or TIP60 Nanoparticles and Delivered as mRNA Elicits Robust Neutralizing Antibody Responses. Vaccines. 2025; 13(8):778.
https://doi.org/10.3390/vaccines13080778
Chicago/Turabian Style
Guest, Johnathan D., Yi Zhang, Daniel Flores, Emily Atkins, Kuishu Ren, Yingyun Cai, Kim Rosenthal, Zimeng Wang, Kihwan Kim, Charles Chen,
and et al. 2025. "SARS-CoV-2 RBD Scaffolded by AP205 or TIP60 Nanoparticles and Delivered as mRNA Elicits Robust Neutralizing Antibody Responses" Vaccines 13, no. 8: 778.
https://doi.org/10.3390/vaccines13080778
APA Style
Guest, J. D., Zhang, Y., Flores, D., Atkins, E., Ren, K., Cai, Y., Rosenthal, K., Wang, Z., Kim, K., Chen, C., Roque, R., Cheng, B., Yanez Arteta, M., Zhou, L., Laliberte, J., & Francica, J. R.
(2025). SARS-CoV-2 RBD Scaffolded by AP205 or TIP60 Nanoparticles and Delivered as mRNA Elicits Robust Neutralizing Antibody Responses. Vaccines, 13(8), 778.
https://doi.org/10.3390/vaccines13080778
